Testing effectiveness (Phase 2)Active Not RecruitingNCT06549114
What this trial is testing
Leniolisib for Immune Dysregulation in PIDs
Who this might be right for
Primary Immunodeficiency Disorders (PIDs)
Pharming Technologies B.V. 12
Showing 3 of 3 results